Literature DB >> 15522442

Respiratory syncytial virus and other pneumoviruses: a review of the international symposium--RSV 2003.

Alexander C Schmidt1, Teresa R Johnson, Peter J M Openshaw, Thomas J Braciale, Ann R Falsey, Lawrence J Anderson, Gail W Wertz, Jessie R Groothuis, Gregory A Prince, Jose A Melero, Barney S Graham.   

Abstract

The Respiratory Syncytial Virus 2003 symposium took place from 8th-11th November 2003 in Stone Mountain, Georgia, and brought together more than 200 international investigators engaged in RSV research. RSV biology, pathogenesis, and clinical data, as well as RSV vaccines and antivirals, were addressed in the meeting, and this review will aim to briefly summarize and discuss the implications of new findings. The meeting also served as the inauguration of the Robert M. Chanock Award for lifetime achievement in RSV research, an award named in honor of the person who started the field of RSV research by recovering the first human RS virus from infants with severe bronchiolitis in 1956.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15522442     DOI： 10.1016/j.virusres.2004.06.008

Source DB:  PubMed          Journal:  Virus Res        ISSN： 0168-1702            Impact factor:   3.303


  8 in total

1.  Novel drugs targeting Toll-like receptors for antiviral therapy.

Authors:  Mira C Patel; Kari Ann Shirey; Lioubov M Pletneva; Marina S Boukhvalova; Alfredo Garzino-Demo; Stefanie N Vogel; Jorge Cg Blanco
Journal:  Future Virol       Date:  2014-09       Impact factor: 1.831

2.  Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells.

Authors:  Ping Liu; Mohammad Jamaluddin; Kui Li; Roberto P Garofalo; Antonella Casola; Allan R Brasier
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

3.  Lower GrB+ CD62Lhigh CD8 TCM effector lymphocyte response to influenza virus in older adults is associated with increased CD28null CD8 T lymphocytes.

Authors:  Dongxu Xie; Janet E McElhaney
Journal:  Mech Ageing Dev       Date:  2007-05-22       Impact factor: 5.432

4.  Increased pathogenesis and inflammation of airways from respiratory syncytial virus infection in T cell deficient nude mice.

Authors:  Juan Zhou; Xi-Qiang Yang; Zhou Fu; Xiao-Dong Zhao; Li-Ping Jiang; Li-Jia Wang; Yu-Xia Cui
Journal:  Med Microbiol Immunol       Date:  2007-12-05       Impact factor: 3.402

5.  Risk factors for severe respiratory syncytial virus lower respiratory tract infection.

Authors:  Constanze Sommer; Bernhard Resch; Eric A F Simões
Journal:  Open Microbiol J       Date:  2011-12-30

6.  Hyperresponsiveness to inhaled but not intravenous methacholine during acute respiratory syncytial virus infection in mice.

Authors:  Rachel A Collins; Rosa C Gualano; Graeme R Zosky; Constance L Atkins; Debra J Turner; Giuseppe N Colasurdo; Peter D Sly
Journal:  Respir Res       Date:  2005-12-05

7.  Unbiased analysis of peripheral blood mononuclear cells reveals CD4 T cell response to RSV matrix protein.

Authors:  Juilee Thakar; Yu Qian; Lauren Benoodt; David Roumanes; Xing Qiu; Nathan Laniewski; ChinYi Chu; Christopher Slaunwhite; Lu Wang; Aishwarya Mandava; Ivan Chang; Ann R Falsey; Mary T Caserta; Thomas J Mariani; Richard H Scheuermann; Edward E Walsh; David J Topham
Journal:  Vaccine X       Date:  2020-04-21

8.  Gene optimization leads to robust expression of human respiratory syncytial virus nucleoprotein and phosphoprotein in human cells and induction of humoral immunity in mice.

Authors:  Fernando M Simabuco; Rodrigo E Tamura; Cassiano Carromeu; Luis E Farinha-Arcieri; Armando M Ventura
Journal:  J Virol Methods       Date:  2009-02-04       Impact factor: 2.014
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.